Compare SKM & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKM | BRKR |
|---|---|---|
| Founded | 1984 | 1960 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 7.0B |
| IPO Year | 1996 | 2000 |
| Metric | SKM | BRKR |
|---|---|---|
| Price | $19.84 | $46.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $49.42 |
| AVG Volume (30 Days) | 785.4K | ★ 2.2M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | ★ 4.34% | 0.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $12,327,044,068.00 | $3,438,900,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | $3.15 | $1.23 |
| P/E Ratio | $19.17 | ★ N/A |
| Revenue Growth | N/A | ★ 6.10 |
| 52 Week Low | $19.67 | $28.53 |
| 52 Week High | $23.80 | $64.64 |
| Indicator | SKM | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 41.35 | 57.08 |
| Support Level | $19.67 | $44.11 |
| Resistance Level | $19.93 | $47.90 |
| Average True Range (ATR) | 0.20 | 1.88 |
| MACD | -0.03 | -0.51 |
| Stochastic Oscillator | 21.02 | 51.03 |
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production as well as developing e-commerce and internet platform businesses, these were all spun off into the separate, SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.